Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Novavax, Inc (NASDAQ:NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat.
Novavax，Inc.納斯達克週三開盤上漲10%，但截至記者發稿時，該股幾乎回吐了全部漲幅，交易基本持平。
The pharmaceutical company's NVX-CoV2373 COVID-19 vaccine was recommended for Emergency Use Authorization for individuals 18 years of age and older by a committee of independent U.S. Food and Drug Administration vaccine advisors. The vaccine will be the fourth available COVID-19 vaccine available in the U.S.
該製藥公司的NVX-CoV2373新冠肺炎疫苗被一個獨立的委員會推薦為18歲及以上個人的緊急使用授權美國食品和藥物管理局疫苗顧問。該疫苗將是美國可用的第四種新冠肺炎疫苗。
The news didn't impress Bank of America analyst Alec Stranahan, who maintained an Underperform rating on the stock with a $35 price target. Stranahan doesn't believe the demand for vaccines outweighs the current supply.
這消息沒有給人留下深刻的印象美國銀行分析員亞歷克·斯特拉漢，他對該股維持了不佳的評級，目標價為35美元。斯特拉漢認為，疫苗的需求不會超過目前的供應。
The brief rally in Novavax appeared likely from a technical perspective, regardless of the news, because the stock has been trading in a downtrend and was due to print a lower high. Although the trend suggests more downside, there are bullish signs on Novavax's chart traders can watch for.
無論有什麼消息，從技術角度來看，Novavax的短暫反彈似乎都是可能的，因為該股一直處於下跌趨勢，並將創下更低的高點。儘管這一趨勢暗示了更多的下行空間，但在Novavax的圖表上有看漲跡象，交易員可以密切關注。
Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial.
想要直接分析嗎？來BZ Pro休息室找我吧！點擊這裏免費試用。
The Novavax Chart: Novavax's downtrend began on May 19 and the stock's most recent lower high was printed on June 1 at $57.49 and the most recent lower low was formed at the $41.10 mark on Monday. Wednesday's high-of-day may mark the next lower high within the downtrend, although more candles will need to print for verification.
Novavax圖表：Novavax的下跌趨勢始於5月19日，該股最近的較低高點是在6月1日打印的57.49美元，最近的較低低點是在週一形成的41.10美元關口。週三的高點可能標誌着下跌趨勢中的下一個較低高點，儘管還需要打印更多蠟燭來驗證。
- Bullish traders will be watching for the double bottom pattern to hold and, perhaps, become recognized, especially if Novavax trades lower to form a triple bottom pattern. The double bottom pattern was printed at the $41.33 on May 12 and Monday and if Novavax can reverse to the upside again at that level it could provide a solid entry point.
- Bullish traders can also take note of the bullish divergence that is occurring on Novavax's chart. Novavax has been trading within the $40 to $63 range since April 7, but the stock's relative strength index has been making a series of higher lows, which indicates Novavax is gaining momentum.
- Bearish traders want to see Novavax continue to reject the eight-day and 21-day exponential moving averages (EMAs), which could continue to guide the stock lower.
- Novavax has resistance above the EMAs at $54.50 and $76.59 and support below at $40.98 and $26.10.
- 看漲的交易員將關注雙底格局能否守住，或許會得到認可，特別是如果Novavax交易走低形成三重底格局的話。雙底形態在5月12日和週一分別印在41.33美元，如果Novavax能夠在該水平再次逆轉上行趨勢，它可能提供一個堅實的切入點。
- 看漲的交易者也可以注意到Novavax圖表上正在發生的看漲背離。自4月7日以來，Novavax的交易價格一直在40美元至63美元的區間內，但該股的相對強弱指數一直在一系列較高的低點，這表明Novavax正在獲得動力。
- 看跌的交易員希望看到Novavax繼續拒絕八日和21日指數移動均線(EMA)，這可能會繼續引導該股走低。
- Novavax在均線上方的阻力位在54.50美元和76.59美元，下方的支撐位在40.98美元和26.10美元。
See Also: How to Read Candlestick Charts for Beginners
另請參閲：如何閲讀初學者的燭臺圖表